Reduction of MS-related scotomata by a new class of potassium channel blockers from Ruta graveolens
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Neuro-Ophthalmology
- Vol. 13 (4) , 191-198
- https://doi.org/10.3109/01658109309038150
Abstract
The effects of the medicinal plant rue (Ruta graveolens L.) on MS-related visual-field defects was tested. In five of nine patients the scotomata were reduced by a single dose of an aqueous extract of 3 g of the drug; the effect was reversible, appearing after only about two hours and lasting for one to two days. There was no detectable action in four patients. In no case were undesirable side effects observed. The problems associated with generalizing and evaluating both clinical findings in MS and the efficacy of treatment are discussed. The observed action of Ruta graveolens is ascribed to the potassium channel blockers the plant contains. The authors have identified these substances as methoxy-substituted psoralens.Keywords
This publication has 19 references indexed in Scilit:
- 4‐Aminopyridine in multiple sclerosisNeurology, 1991
- Über neurogene Wirkungen von Ruta graveolensPublished by Springer Nature ,1990
- Effects ofRutaon the Excitation Process in Myelinated NervesPlanta Medica, 1989
- A new approach for the treatment of demyelinating diseases?Journal of Neuroimmunology, 1988
- 4‐Aminopyridine improves clinical signs in multiple sclerosisAnnals of Neurology, 1987
- ReplyAnnals of Neurology, 1986
- 4-aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerveBrain Research, 1985
- Effects of 4-aminopyridine in patients with multiple sclerosisJournal of the Neurological Sciences, 1983
- Evidence for the presence of potassium channels in the internode of frog myelinated nerve fibres.The Journal of Physiology, 1982
- Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibresNature, 1980